(3R*,4R*)-4-((3-Methyl-2-oxo-1,2-dihydro-1,7-naphthyridin-8-yl)amino)-N-(tetrahydro-2H-pyran-4-yl)piperidine-3-carboxamide

ID: ALA4752082

Chembl Id: CHEMBL4752082

PubChem CID: 162652853

Max Phase: Preclinical

Molecular Formula: C20H27N5O3

Molecular Weight: 385.47

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1cc2ccnc(N[C@@H]3CCNC[C@H]3C(=O)NC3CCOCC3)c2[nH]c1=O

Standard InChI:  InChI=1S/C20H27N5O3/c1-12-10-13-2-7-22-18(17(13)25-19(12)26)24-16-3-6-21-11-15(16)20(27)23-14-4-8-28-9-5-14/h2,7,10,14-16,21H,3-6,8-9,11H2,1H3,(H,22,24)(H,23,27)(H,25,26)/t15-,16-/m1/s1

Standard InChI Key:  YJYLTSMMMZXXPP-HZPDHXFCSA-N

Alternative Forms

1. Parent:

   

   ALA4752082

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 385.47

Molecular Weight (Monoisotopic): 385.2114

AlogP: 0.92

#Rotatable Bonds: 4

Polar Surface Area: 108.14

Molecular Species: BASE

HBA: 6

HBD: 4

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 12.99

CX Basic pKa: 9.25

CX LogP: -0.53

CX LogD: -2.39

Aromatic Rings: 2

Heavy Atoms: 28

QED Weighted: 0.62

Np Likeness Score: -0.49

References

1. Watson RJ,Bamborough P,Barnett H,Chung CW,Davis R,Gordon L,Grandi P,Petretich M,Phillipou A,Prinjha RK,Rioja I,Soden P,Werner T,Demont EH.  (2020)  GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins.,  63  (17): [PMID:32691589] [10.1021/acs.jmedchem.0c00614]

Source

Source(1):

• Scientific Literature